Patent directory · USPTO A61K / A61P
Patents matching “Northwestern University”
565 pharma patents match "Northwestern University" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 565 pharmaceutical patents matching "Northwestern University" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9707281
Pharmaceutical compositions and methods for digesting atherosclerotic plaques
granted -
US 9701733
Maspin-based treatment of cancer
granted -
US 9701661
2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase
granted -
US 9688637
3-amidobenzamides and uses thereof for increasing cellular levels of A3G and other A3 family members
granted -
US 9677075
Metal-ligand coordination polymer nanoparticles and methods for making
granted -
US 9675607
Epimorphic regeneration and related hydrogel delivery systems
granted -
US 9670141
(S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma
granted -
US 9669014
Small molecule inhibitors of superoxide dismutase expression
granted -
US 9663468
2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition
granted -
US 9663493
Pyridazine compounds, compositions and methods
granted -
US 9655917
Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups
granted -
US 9650421
Self-assembled nanostructures
granted -
US 9642805
Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy
granted -
US 9636329
Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors
granted -
US 9636374
pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics
granted -
US 9637597
DOPA-melanin formation in high ionic strength solutions
granted -
US 9623124
Multimodal diagnostic technology for early stage cancer lesions
granted -
US 9616113
Peptide conjugated particles
granted -
US 9617541
Biocompatible infinite coordination polymer nanoparticle-nucleic acid conjugates for antisense gene regulation
granted -
US 9615758
Contribution of oxidative stress to AF electrograms
granted -
US 9605054
Composition and method for treating a tauopathy
granted -
US 9603820
Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma
granted -
US 9593145
Secondary structure stabilized NMDA receptor modulators and uses thereof
granted -
US 9593069
Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis
granted